维普期刊资源整合服务平台（V6.5）

52篇 您的检索式：作者名="Kessler CM"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Randomised con-trolled trial of recombinant tissue plasminogen activator versus uro-kinase in the tretment of acute pulmonary embolism显示文摘	Goldhaber SZ Kessler CM Heit J	1988	Lancet1988，2，3：	1
2	Randomized controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism显示文摘	Kessler CM Heit J	1988	Lancet1988，2，8606：	1
3	Recombinant tis-suetype plasminogen activator versus a novel dosing regimen ofurkinase in acute pulmonary embolism:a randomized comtrolledmulticenter trial显示文摘	Goldhaber SZ Kessler CM Heit JA	1992	J Am Coll Cardiol1992，20，1：	1
4	The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A 显示文摘	Lusher M Lee CA Kessler CM	2003	Haemophilia2003，9，1：	1
5	Reversal of warfarin-induced excessive anticoagulation with recombinant human factor Ⅶ a concentrate 显示文摘	Kessler CM	2002	Ann Intern Med2002，137，：	1
6	Intermittent pneumatic compression in chronic venous insufficiency favorably affects fi- brinolytic potential and platelet activation显示文摘	Kessler CM Hirsch DR Jacobs H	1996	Blood Coagul Fibri- nolysis1996，7，4：	1
7	Acquired inhibitors 显示文摘	Cohen A J Kessler CM	1996	Baillieres Clin Haematol1996，9，2：	1
8	The link between cancer and venous thromboembolism:a review显示文摘	Kessler CM		0，，4：	1
9	Acquired factor Ⅶ autoantibody inhibitors: current concept and potential therapeutic strategies for the future 显示文摘	Kessler CM	2000	Haematologica2000，85，10：	1
10	D-dimer testing:the role of the clinical laboratory in the diagsosis of pulmonary embolism显示文摘	Mavromatis BH Kessler CM	2001	J Clin Pathol2001，54，：	1
11	Recombinant tissue type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial显示文摘	Goldhaber SZ Kessler CM Heit JA	1992	J Am Coll Cardiol1992，20，：	1
12	Diagnosis and treatment of yon Willebranddisease: new perspectives and nuances 显示文摘	Kessler CM	2007	Haemophilia2007，13，5：	1
13	Perspectives on treatment of acute pulmonary embolism with tissue plasntinogen activator显示文摘	Goldhaber SZ Markis JE Kessler CM	1987	Semin Thromb Hemost1987，13，2：	1
14	Randomized,controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism显示文摘	Goldhaber SZ Kessler CM Heir J		0，，8606：	1
15	Recombinant tissue plasminogen activator versus a novel dosingregimen of urokinase in acute pulmonary embolism:a randomized,controlled,multicenter trial显示文摘	Goldhaber SZ Kessler Cm Heit J		0，，01：	1
16	Diagnosis and treatment of von Willebrand disease:new perspectives and nuances显示文摘	Kessler CM	2007	Hemophilia2007，13，：	1
17	Prevention and management of thromboembolism 显示文摘	Kessler CM	2011	Clinical Advances in Hematology & Oncology H & O2011，9，1：	1
18	Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism显示文摘	Goldhaber SZ Kessler CM Heit JA	1992	J Am Coll Cardiol1992，20，：	1
19	The suprapharmacological dosing of antithrombin concentrate for Staphylococcus aureus-induced Disseminated intravascular coagulation in guinea pigs:substantial reduction in mortality and morbidity显示文摘	Kessler CM Tang Z Jacobs HM	1997	Blood1997，89，12：	1
20	Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial显示文摘	Kessler CM Heit JA	1992	J Am Coll Cardiol1992，20，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示